Canada markets closed

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.73-0.25 (-1.79%)
At close: 04:00PM EDT
13.65 -0.08 (-0.58%)
After hours: 05:56PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
2018-12-31
Total Revenue
100,215
96,148
42,087
25,000
0
Cost of Revenue
3,092
2,932
225
-
-
Gross Profit
97,123
93,216
41,862
-
-
Operating Expenses
Research Development
248,771
257,040
198,970
157,610
82,887
Selling General and Administrative
133,827
136,253
114,082
68,116
21,212
Total Operating Expenses
382,598
393,293
313,052
225,726
104,099
Operating Income or Loss
-285,475
-300,077
-271,190
-200,726
-104,099
Interest Expense
-
0
0
67
84
Income Before Tax
-285,558
-299,964
-266,489
-192,256
-99,854
Income from Continuing Operations
-285,558
-299,964
-266,489
-192,256
-99,854
Net Income
-285,558
-299,964
-266,489
-192,256
-99,854
Net Income available to common shareholders
-285,558
-299,964
-266,489
-192,256
-99,854
Basic EPS
-
-5.16
-4.78
-4.48
-2.82
Diluted EPS
-
-5.16
-4.78
-4.48
-2.82
Basic Average Shares
-
58,084
55,781
42,869
35,390
Diluted Average Shares
-
58,084
55,781
42,869
35,390
EBITDA
-
-296,950
-264,184
-191,359
-99,453